Press Releases
Archives:
2007 » »
2008 » »
2009 » »
2010 » »
| December 10, 2008 |
EKR Therapeutics Commences Shipments of Premixed Double
Concentration CardeneŽ I.V. (nicardipine hydrochloride) Ready-to-Use Bags
» more
|
| November 11, 2008 |
EKR Therapeutics to Present at the Lazard Capital Markets Healthcare Conference
» more
|
| November 11, 2008 |
EKR Therapeutics Broadens Its Ready-to-Use CardeneŽ I.V. Product Offerings with FDA Approval of Double Concentration Premixed I.V. Bags
» more
|
| September 16, 2008 |
EKR Therapeutics to Present at the UBS 2008 Global Life Sciences Conference
» more
|
| August 1, 2008 |
EKR Therapeutics Receives Approval for Ready-to-Use Intravenous Bags of CardeneŽI.V.
» more
|
| July 16, 2008 |
URGENT Study Provides Important New Insight into the Use of Dyspnea as a Clinical Endpoint for Evaluating New Treatments for Acute Heart Failure Syndromes
» more
|
| March 27, 2008 |
EKR Therapeutics Appoints Co-Founder Richard DeSimone as COO
» more
|
| March 27, 2008 |
EKR Therapeutics Announces Management Additions and Promotions, Reflecting Support of Continued Acceleration in Growth
» more
|
| March 10, 2008 |
EKR Therapeutics Raises Over $145 Million in Support of Growth
» more
|
| February 4, 2008 |
EKR THERAPEUTICS AND PDL BIOPHARMA SIGN ASSET PURCHASE AGREEMENT FOR CARDIOVASCULAR PRODUCTS
» more
|
|
